OXFORD GENETICS
Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.
OXFORD GENETICS
Industry:
Biotechnology Genetics
Founded:
2011-04-28
Address:
Upper Heyford, Somerset, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxgene.com
Total Employee:
51+
Status:
Active
Contact:
+44 18 6923 8004
Email Addresses:
[email protected]
Total Funding:
16.76 M GBP
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS Microsoft Microsoft Azure Shutterstock Symantec Secure Site KnowBe4
Current Employees Featured
Founder
Investors List
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Invesco Perpetual
Invesco Perpetual investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Oxford Genetics
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Grant - Oxford Genetics
Innovate UK
Innovate UK investment in Grant - Oxford Genetics
Mercia Fund Managers
Mercia Fund Managers investment in Venture Round - Oxford Genetics
Mercia Fund Managers
Mercia Fund Managers investment in Seed Round - Oxford Genetics
Newest Events participated
Official Site Inspections
http://www.oxgene.com
- Host name: 20.49.151.14
- IP address: 20.49.151.14
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Oxford Genetics"
OXGENE
OXGENE is the innovation arm of WuXi Advanced Therapies, providing expert design and engineering services for viral vector optimisation and cell line development, seamlessly integrated with WuXi Advanced Therapiesโ GMP โฆSee details»
Our People - OXGENE
Meet the people leading OXGENE's open minded, collaborative and ambitious scientific and commercial teams. Keith Meaney General Manager. Keith Meaney was appointed as General โฆSee details»
OXGENE | Lab Manager
Mar 5, 2021 Organization profile for OXGENE on Lab Manager. OXGENE OXGENE, a WuXi Advanced Therapies company, accelerates the delivery of gene therapy and biologics with its โฆSee details»
WuXi AppTec Completes Acquisition of OXGENE to Further โฆ
Mar 1, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology โฆSee details»
OXGENE - LinkedIn
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and โฆSee details»
OXGENE - LinkedIn
OXGENE | 6,898 followers on LinkedIn. A WuXi Advanced Therapies company, based in Oxford, UK. | OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking โฆSee details»
WuXi AppTec Completes Acquisition of OXGENE to Further โฆ
Mar 2, 2021 OXGENE will become a fully-owned subsidiary of WuXi Advanced Therapies (WuXi ATU), WuXi AppTec's cell and gene therapy Contract Testing, Development and โฆSee details»
OXGENE Overview | SignalHire Company Profile
Organization Website: oxgene.com : Phone Number +44 1865 415 107: OXGENE industries BiotechSee details»
OXGENE (Oxford Genetics) - VentureRadar
May 1, 2020 OXGENE find solutions to seemingly impossible problems. We develop new technologies in mammalian cell engineering along the whole spectrum from discovery science โฆSee details»
Oxford Genetics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +44 18 6923 8004 Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and โฆSee details»
WuXi AppTec Acquires OXGENE as Its First Cell & Gene Therapy ...
Mar 11, 2021 WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. โฆSee details»
OXGENE
OXGENE provides an integrated solution that supports your entire discovery and validation workflow. GET IN TOUCH Are you ready for GMP Manufacture? WuXi Advanced Therapies is a global Contract Testing, Development and โฆSee details»
WuXi AppTec Completes Acquisition of OXGENE to Further โฆ
Mar 3, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology โฆSee details»
OXGENE Company Profile - Office Locations, Competitors, โฆ
OXGENE has 5 employees across 2 locations and £1.01 m in annual revenue in FY 2018. See insights on OXGENE including office locations, competitors, revenue, financials, executives, โฆSee details»
Oxgene Company Profile 2024: Valuation, Investors, Acquisition
Oxgene was founded in 2011. Where is Oxgene headquartered? Oxgene is headquartered in Oxford, United Kingdom. What is the size of Oxgene? Oxgene has 103 total employees. What โฆSee details»
OXGENE - Products, Competitors, Financials, Employees, โฆ
About OXGENE. OXGENE's technology platforms and solutions accelerate the discovery, development, and manufacture of cell and gene therapies. The firm provides high-titer viral โฆSee details»
Oxgene Company Profile Funding & Investors | YourStory
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and โฆSee details»
OXGENE - The Oxford Magazine
Apr 2, 2020 OXGENE. Life Sciences. WuXi AppTec completes acquisition of Oxford-based OXGENE. This acquisition enables WuXi AppTec to offer its customers end-to-end support in โฆSee details»
OXGENE
WEIHENG SU, PH.D. HEAD OF AAV, OXGENE & WuXi ATU ... WuXi Advanced Therapies is a global Contract Testing, Development and Manufacturing Organization (CTDMO) dedicated to โฆSee details»